Iris Gluck
- Otorhinolaryngology top 1%
- Head and Neck Cancer Studies 13
- Oncology top 5%
- Cancer Immunotherapy and Biomarkers 6
- Cancer Risks and Factors 2
- Colorectal Cancer Treatments and Studies 2
- Cancer Diagnosis and Treatment 2
- Surgery top 10%
- Head and Neck Surgical Oncology 8
-
- Dysphagia Assessment and Management 2
-
- Cancer Genomics and Diagnostics 2
- Co-authors
- Tanguy Y. SeiwertJared WeissBarbara BurtnessJonathan D. ChengLaura Q.M. ChowJoseph P. EderMakoto TaharaRobert I. Haddad
- Journals
- International Journal of Radiation Oncology*Biology*Physics (6 papers)Journal of Clinical Oncology (3 papers)Radiotherapy and Oncology (1 paper)
- Partner nations
- IsraelUnited StatesJapan
In The Last Decade
Iris Gluck
26 papers receiving 1.0k citations
Hit Papers
Peers
Comparison fields: 5 of 62
- Otorhinolaryngology 369
- Oncology 634
- Pulmonary and Respiratory Medicine 307
- Immunology 173
- Surgery 303
Countries citing papers authored by Iris Gluck
This map shows the geographic impact of Iris Gluck's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Iris Gluck with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Iris Gluck more than expected).
Fields of papers citing papers by Iris Gluck
This network shows the impact of papers produced by Iris Gluck. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Iris Gluck. The network helps show where Iris Gluck may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Iris Gluck, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2023 | 1 | |
| 2 | 2022 | 54 | |
| 3 | 2018 | 46 | |
| 4 | 2018 | 11 | |
| 5 | 2018 | 34 | |
| 6 | Efficacy and safety of pembrolizumab in recurrent/metastatic head and neck squamous cell carcinoma: pooled analyses after long-term follow-up in KEYNOTE-012breakdown → | 2018 | 329 |
| 7 | 2017 | 40 | |
| 8 | 2016 | 3 | |
| 9 | 2014 | 1 | |
| 10 | 2014 | 23 | |
| 11 | 2013 | 18 | |
| 12 | 2012 | 38 | |
| 13 | 2010 | 11 | |
| 14 | 2010 | 54 | |
| 15 | 2009 | 9 | |
| 16 | 2009 | 95 | |
| 17 | 2009 | 29 | |
| 18 | 2009 | 3 | |
| 19 | 2008 | 40 | |
| 20 | 2006 | 53 |
About Iris Gluck
Iris Gluck is a scholar working on Otorhinolaryngology, Oncology, Speech and Hearing, Internal Medicine and Cancer Research, having authored 26 papers that have together received 1.0k indexed citations. Recurring topics across this work include Head and Neck Cancer Studies (13 papers), Head and Neck Surgical Oncology (8 papers), Cancer Immunotherapy and Biomarkers (6 papers), Cancer Risks and Factors (2 papers), Colorectal Cancer Treatments and Studies (2 papers), Cancer Diagnosis and Treatment (2 papers), Dysphagia Assessment and Management (2 papers) and Cancer Genomics and Diagnostics (2 papers). The work is most often cited by research in Otorhinolaryngology (369 citations), Oncology (634 citations), Pulmonary and Respiratory Medicine (307 citations), Immunology (173 citations) and Surgery (303 citations). Iris Gluck has collaborated with scholars based in Israel, United States and Japan. Frequent co-authors include Tanguy Y. Seiwert, Jared Weiss, Barbara Burtness, Jonathan D. Cheng, Laura Q.M. Chow, Joseph P. Eder, Makoto Tahara, Robert I. Haddad, Ranee Mehra and Hyunseok Kang. Their work appears in journals such as International Journal of Radiation Oncology*Biology*Physics, Journal of Clinical Oncology, Radiotherapy and Oncology, Blood Coagulation & Fibrinolysis and British Journal of Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.